The secretions of our bodies are full of chemicals and substances, and we’re not sure how we get them to where they are.
But the mystery of what makes them and how they’re created is getting more and more intriguing.
We know that they come from our own saliva, which is why we have to wash our hands a lot.
And now, scientists have discovered a different type of secretion that is even more mysterious.
They think they’ve found the secretion responsible for a bunch of things.
What they’re talking about is the vesicular secretions.
And they are making a lot of these secretions in our bodies, so they are a key ingredient for us to think of our body as being a living organism.
“We know that the secretions are made from our saliva, and so the question becomes, how does that work?” said Dr. Michael Goggin, the lead author of a study in the Journal of the American Medical Association.
The researchers, led by Dr. Gogins lab at the University of Utah, discovered the secreted secretions after analyzing the body fluids of about 2,000 people, and the scientists found a bunch in all.
They are made by different types of bacteria and viruses, and their activity was tied to how often we spit and the time it takes for the saliva to make the secretes.
And the more often you spit, the higher the activity of those secretions would be.
And in this case, that activity is associated with our saliva being able to produce a bunch more of these types of secretions as we age.
The team’s findings have led to a new type of therapy for those with oral diseases.
The study focused on oral diseases like eczema, inflammatory bowel disease, and ulcerative colitis, and it also included people who have type 1 diabetes, but those patients are still at high risk of developing diseases like COPD and diabetes.
And, as Dr. Andrew Gopnik, one of the authors, told Polygon, these people have a lot to be concerned about, because they have these oral diseases that are also at risk for a whole host of other diseases.
They’re all on the list of “progressive oral diseases,” which are diseases that worsen with age.
“You know, we think of these things as like chronic diseases that can go on forever,” Gopnick said.
“But in people like those with these diseases, we’re talking of disease that is progressive, so it can become chronic.”
It’s not just a question of having one or two of these diseases.
People also have many other problems like chronic pain, chronic heart disease, or asthma.
And those diseases have a much higher incidence in people with type 1 and type 2 diabetes.
So this study found that the risk of being at risk of chronic diseases like these was even higher in people who had oral disease.
This is a big deal.
Type 1 diabetes is not uncommon, and type 1 diabetics have an estimated 15 to 25 percent of their body fat.
And while that’s not as high as the rate of obesity or smoking, it’s still quite high.
“If we’re able to reduce the incidence of diabetes in the general population by 30 to 40 percent, we could potentially reduce the overall prevalence of the disease and it’s actually a pretty big deal,” Gogin said.
But there are also some things the researchers aren’t quite sure about.
For example, why are these types being produced in certain people, but not others?
It’s possible that the bacteria and viral load in our saliva may be a factor.
“It may be that there’s something that’s going on in the saliva that allows for some of these viruses to bind to certain proteins and bind to the secretors and the proteins can be a source of the secretor secretions,” Gotnik said.
And if that’s the case, maybe we should try to develop treatments for some other conditions too.
“I think it’s also important to point out that these types aren’t going to be cured by some type of surgery or even a pill, but it might be possible to reduce their risk by reducing their exposure to certain environmental toxins.”
Gogini says the next step is to do a larger study of the saliva secretions that are produced in people, so that we can see what type of activity they are producing and how common it is.
“That’s a very exciting step, because we’re getting a lot more information from different populations of people about the secretory secretions and we may start to develop therapies to address the underlying causes of these disease,” he said.
The next steps in this study will be to look at the secretorial secretions produced by people over time and determine how often they change over time.
And hopefully, Gogigan will be able to develop a drug to treat some of those diseases and other diseases that may be associated with the production of